These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25589666)

  • 21. In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease.
    Chahine LM; Beach TG; Brumm MC; Adler CH; Coffey CS; Mosovsky S; Caspell-Garcia C; Serrano GE; Munoz DG; White CL; Crary JF; Jennings D; Taylor P; Foroud T; Arnedo V; Kopil CM; Riley L; Dave KD; Mollenhauer B;
    Neurology; 2020 Sep; 95(9):e1267-e1284. PubMed ID: 32747521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease.
    Miki Y; Tomiyama M; Ueno T; Haga R; Nishijima H; Suzuki C; Mori F; Kaimori M; Baba M; Wakabayashi K
    Neurosci Lett; 2010 Jan; 469(3):357-9. PubMed ID: 20026177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease.
    Gibbons CH; Garcia J; Wang N; Shih LC; Freeman R
    Neurology; 2016 Aug; 87(5):505-12. PubMed ID: 27385742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colonic bacterial composition in Parkinson's disease.
    Keshavarzian A; Green SJ; Engen PA; Voigt RM; Naqib A; Forsyth CB; Mutlu E; Shannon KM
    Mov Disord; 2015 Sep; 30(10):1351-60. PubMed ID: 26179554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects.
    Kim JS; Park IS; Park HE; Kim SY; Yun JA; Jung CK; Sung HY; Lee JK; Kang WK
    Neurol Sci; 2017 Jan; 38(1):171-179. PubMed ID: 27803984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease.
    Vicente Miranda H; Cássio R; Correia-Guedes L; Gomes MA; Chegão A; Miranda E; Soares T; Coelho M; Rosa MM; Ferreira JJ; Outeiro TF
    Sci Rep; 2017 Oct; 7(1):13713. PubMed ID: 29057912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential sources of interference with the highly sensitive detection and quantification of alpha-synuclein seeds by qRT-QuIC.
    Ruf VC; Shi S; Schmidt F; Weckbecker D; Nübling GS; Ködel U; Mollenhauer B; Giese A
    FEBS Open Bio; 2020 May; 10(5):883-893. PubMed ID: 32190992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
    El-Agnaf OM; Salem SA; Paleologou KE; Curran MD; Gibson MJ; Court JA; Schlossmacher MG; Allsop D
    FASEB J; 2006 Mar; 20(3):419-25. PubMed ID: 16507759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous Alpha-Synuclein From Paraffin Embedded Autopsy Specimens in Parkinson's Disease.
    Gibbons CH; Wang N; Freeman R
    J Parkinsons Dis; 2017; 7(3):503-509. PubMed ID: 28582870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Author response.
    Visanji NP; Lang AE; Hazrai LN
    Neurology; 2015 Sep; 85(9):834-5. PubMed ID: 26554095
    [No Abstract]   [Full Text] [Related]  

  • 31. Submandibular gland is a suitable site for alpha synuclein pathology in Parkinson disease.
    Shin J; Park SH; Shin C; Kim JH; Yun TJ; Kim HJ; Jeon B
    Parkinsonism Relat Disord; 2019 Jan; 58():35-39. PubMed ID: 30340912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers.
    Dokleja L; Hannula MJ; Myöhänen TT
    Neurosci Lett; 2014 Nov; 583():37-42. PubMed ID: 25240592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease.
    Pouclet H; Lebouvier T; Coron E; Des Varannes SB; Neunlist M; Derkinderen P
    Neurogastroenterol Motil; 2012 Apr; 24(4):e202-5. PubMed ID: 22292943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
    Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
    J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease.
    Donadio V; Incensi A; Leta V; Giannoccaro MP; Scaglione C; Martinelli P; Capellari S; Avoni P; Baruzzi A; Liguori R
    Neurology; 2014 Apr; 82(15):1362-9. PubMed ID: 24634456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings.
    Adler CH; Dugger BN; Hentz JG; Hinni ML; Lott DG; Driver-Dunckley E; Mehta S; Serrano G; Sue LI; Duffy A; Intorcia A; Filon J; Pullen J; Walker DG; Beach TG
    Mov Disord; 2016 Feb; 31(2):250-6. PubMed ID: 26799362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symmetry of synuclein density in autopsied Parkinson's disease submandibular glands.
    Adler CH; Serrano GE; Shill HA; Driver-Dunckley E; Mehta SH; Zhang N; Glass M; Sue LI; Intorcia A; Beach TG
    Neurosci Lett; 2024 Mar; 825():137702. PubMed ID: 38395191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits.
    Hatami A; Chesselet MF
    Curr Top Behav Neurosci; 2015; 22():303-30. PubMed ID: 25218491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fundamental limit of alpha-synuclein pathology in gastrointestinal biopsy as a pathologic biomarker of Parkinson's disease: Comparison with surgical specimens.
    Shin C; Park SH; Yun JY; Shin JH; Yang HK; Lee HJ; Kong SH; Suh YS; Shen G; Kim Y; Kim HJ; Jeon B
    Parkinsonism Relat Disord; 2017 Nov; 44():73-78. PubMed ID: 28923294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson's disease.
    Sade O; Fischel D; Barak-Broner N; Halevi S; Gottfried I; Bar-On D; Sachs S; Mirelman A; Thaler A; Gour A; Kestenbaum M; Gana Weisz M; Anis S; Soto C; Roitman MS; Shahar S; Doppler K; Sauer M; Giladi N; Lev N; Alcalay RN; Hassin-Baer S; Ashery U
    Front Mol Neurosci; 2024; 17():1431549. PubMed ID: 39296283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.